World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
78
Citations
22107
World Ranking
1278
National Ranking
111

Medicine

D-Index
79
Citations
23287
World Ranking
17544
National Ranking
1590

Research.com Recognitions

  • 2014 - Chalmers Medal, Royal Society of Tropical Medicine and Hygiene
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Philip Bejon is affiliated with the University of Oxford in the United Kingdom and has a research portfolio primarily situated within the field of medicine, with a focus on infectious diseases. Their work encompasses subfields including infectious diseases, public health, environmental and occupational health, immunology, modeling and simulation, and molecular biology.

The scientist's research spans a number of significant topics such as malaria research and control, SARS-CoV-2 and COVID-19 research, mosquito-borne diseases and control, COVID-19 epidemiological studies, viral infections and outbreaks research, SARS-CoV-2 detection and testing, and COVID-19 clinical research studies.

Philip Bejon has contributed to several recent scientific papers. Notable publications include:

  • Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors (2020, Science)
  • Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial (2024, The Lancet)
  • Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans (2021, Cell Reports)
  • An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples (2021, Wellcome Open Research)
  • Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples (2023, Wellcome Open Research)

Frequent co-authors of Philip Bejon include:

  • Lynette Isabella Ochola-Oyier
  • Charles N. Agoti
  • Benjamin Tsofa
  • Melissa C. Kapulu
  • John N. Gitonga

The scientist regularly publishes in venues such as Harvard Dataverse, Wellcome Open Research, bioRxiv (Cold Spring Harbor Laboratory), London School of Hygiene & Tropical Medicine, and Frontiers in Immunology.

Philip Bejon has been recognized with the Chalmers Medal from the Royal Society of Tropical Medicine and Hygiene in 2014 and has been named a Fellow of The Academy of Medical Sciences in the United Kingdom.

Best Publications

  • First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

    Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;Solange Solmeheim Soulanoudjingar;Solange Solmeheim Soulanoudjingar

  • Oral versus intravenous antibiotics for bone and joint infection

    Li H-K.;Li H-K.;I Rombach;R Zambellas;A S Walker

  • A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

    Selidji Todagbe Agnandji;Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;José Francisco Fernandes;José Francisco Fernandes

  • Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age

    Philip Bejon;John Lusingu;Ally Olotu;Amanda Leach

  • Genetic diversity of the African malaria vector Anopheles gambiae.

    Alistair Miles;Alistair Miles;Nicholas J. Harding;Giordano Bottà;Giordano Bottà;Chris S. Clarkson;Chris S. Clarkson

  • Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

    Ally Olotu;Gregory Fegan;Juliana Wambua;George Nyangweso

  • Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

    Selidji T Agnandji;Angela Huttner;Madeleine E Zinser;Patricia Njuguna

  • Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

    Daniel E Neafsey;Michal Juraska;Trevor Bedford;David Benkeser

  • Upregulation of TGF-β, FOXP3, and CD4+CD25+ Regulatory T Cells Correlates with More Rapid Parasite Growth in Human Malaria Infection

    Michael Walther;Jon Eric Tongren;Laura Andrews;Daniel Korbel

  • One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome

    I. Byren;P. Bejon;P. Bejon;B. L. Atkins;B. L. Atkins;B. Angus

  • Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

    Michael T. White;Robert Verity;Jamie T. Griffin;Kwaku Poku Asante

  • Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure

    Ally Olotu;Gregory Fegan;Juliana Wambua;George Nyangweso

  • Chronic Exposure to Plasmodium falciparum Is Associated with Phenotypic Evidence of B and T Cell Exhaustion

    Joseph Illingworth;Noah S. Butler;Sophie Roetynck;Sophie Roetynck;Jedida Mwacharo

  • Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors

    Sophie Uyoga;Ifedayo M. O. Adetifa;Ifedayo M. O. Adetifa;Henry K. Karanja;James Nyagwange

  • Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya

    Philip Bejon;Thomas N. Williams;Thomas N. Williams;Anne Liljander;Abdisalan M. Noor;Abdisalan M. Noor

  • Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

    Daniel P. Webster;Susanna Dunachie;Jenni M. Vuola;Tamara Berthoud

  • Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

    Unknown

  • Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology

    P. Bejon;A. Berendt;B. L. Atkins;B. L. Atkins;N. Green

  • The prevalence of Plasmodium falciparum in sub-Saharan Africa since 1900

    Robert W. Snow;Benn Sartorius;David Kyalo;Joseph Maina

  • Prevalence of vitamin D deficiency in Africa: a systematic review and meta-analysis.

    Reagan M Mogire;Reagan M Mogire;Agnes Mutua;Wandia Kimita;Alice Kamau

  • A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

    S. J. Dunachie;M. Walther;J. E. Epstein;S. Keating

  • Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.

    Ally Olotu;John Lusingu;John Lusingu;Amanda Leach;Marc Lievens

Frequent Co-Authors

Kevin Marsh
Kevin Marsh University of Oxford
Thomas N. Williams
Thomas N. Williams Imperial College London
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Dominic P. Kwiatkowski
Dominic P. Kwiatkowski University of Oxford
Robert W. Snow
Robert W. Snow Kenya Medical Research Institute
Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
J. Anthony G. Scott
J. Anthony G. Scott University of London
James A. Berkley
James A. Berkley University of Oxford
Brett Lowe
Brett Lowe London School of Hygiene & Tropical Medicine
Andrew M. Prentice
Andrew M. Prentice London School of Hygiene & Tropical Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degree options related to Microbiology can open doors to diverse career opportunities. For those interested in public health, programs like the best easiest mph online programs to get into offer flexible pathways to advance your knowledge without the traditional barriers of on-campus study.

Careers such as becoming a child life specialist salary show how science backgrounds can translate to roles supporting health and wellbeing beyond the microbiology lab, combining empathy with specialized training.

For individuals facing unique challenges, including those with legal histories, there are also viable academic routes. Innovative resources highlighting the degrees for felons emphasize that a micro-focused scientific career is achievable with the right support and education.

Additionally, healthcare-focused careers such as a functional medicine nurse practitioner blend clinical expertise with holistic care, integrating microbiological principles in treating patients more effectively.

Best Scientists Citing Philip Bejon

Trending Scientists